Fort LP’s Integra LifeSciences IART Stock Holding History

Fort LP’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-348	Closed	-$20K	–	420
2019 Q4	$20K	Sell	348 -305	-47%	-$18.2K	﹤0.01%	437
2019 Q3	$39K	Buy	653 +105	+19%	+$6.26K	0.01%	382
2019 Q2	$31K	Buy	+548	New	+$28.2K	0.01%	397
2019 Q1	–	Sell	-762	Closed	-$34K	–	474
2018 Q4	$34K	Buy	+762	New	+$41.8K	0.01%	366

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fort LP's IART Position: Q1 2020 in Review

Fort LP sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 348 shares — an estimated $20K sold.

Fort LP first reported a position in IART in Q4 2018 and held it in 4 quarters. The position peaked at $39K in Q3 2019. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Fort LP reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Fort LP sold 348 Integra LifeSciences shares in Q1 2020, an estimated $20K.
Fort LP first reported a position in Integra LifeSciences in Q4 2018 and held it in 4 quarters.
Fort LP's Integra LifeSciences position peaked at $39K in Q3 2019.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Fort LP's 13F filing for Q1 2020, filed 14 May 2020.